Sareum Holdings (FRA:RYH0) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RYH0 Sareum Holdings PLC FRA:RYH0
36 GF Score
Price €0.23
! 3 Warning Signs
View Full Analysis

What is Sareum Holdings FFO?

FFO (Funds from operations) only applies to REITs.

FRA:RYH0
36GF Score
Sareum Holdings PLC FRA:RYH0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sareum Holdings Business Description

Other Exchanges SAR:UK
Address Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.
36GF Score

Get the complete analysis for FRA:RYH0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.23
Price